Jubilant Pharmova Limited
Jubilant Pharmova Limited is a Public Non-govt company company incorporated in 1978 and based in Uttar Pradesh, India. Jubilant Pharmova Limited operates in Alcohols, manufacturing (NIC 24116) with authorized capital of ₹143.02 Cr and paid-up capital of ₹15.93 Cr. For 2025-26, the company reported revenue of ₹263.50 Cr and profit after tax of ₹63.20 Cr. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
JUBILANT PHARMOVA LIMITED is the legal entity of Jubilant Biosys, Jubilant Pharmova and Jubilant Pharma.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 26 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +23d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Jubilant Pharmova Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 113000833 | ICICI Bank Ltd(Bank) | ₹1.26 Cr | 19 Sep 2023 | Satisfied |
| 172098160 | State Bank of India(Bank) | ₹8.16 Cr | 19 Sep 2019 | Open |
| 887930023 | ICICI Bank Ltd(Bank) | ₹4.52 Cr | 27 Jan 2019 | Satisfied |
| 337772528 | State Bank of India(Bank) | ₹24.43 Cr | 27 Jan 2019 | Satisfied |
| 770977001 | Axis Bank Ltd(Bank) | ₹3.10 Cr | 27 Jan 2023 | Satisfied |
Charge IDs, lenders & amounts for Jubilant Pharmova Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2025-26 | — | ||||
| 2014-15 | — |
Detailed Financials
2 FYs| Line item | 2025-26 | 2014-15 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2025-26 | -41.0% | — | — | |
| Profit after Tax2025-26 | -27.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2014-15 | +6.25% | — | +10.55% | +3.95% | — | |||
| 2025-26 | +23.98% | -91.97% | — | — | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,71,57,485 | 87.27% |
| Institutional Investors | 3 | 9,31,886 | 2.99% |
| Public & Others | 20 | 30,30,890 | 9.74% |
Promoter, institutional & public holding for Jubilant Pharmova Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
10 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.